1-Perhydro-2H-pyran-2-yl-3-[3-(3-piperidylpropanoylamino)phenyl]-1H-indazole-5-carboxamide → 3-[3-(3-Piperidylpropanoylamino)Phenyl]-1H-Indazole-5-Carboxamide

HRID 1349793Notes

Reaction equation

HRID 1349793 reaction equation
O1CCCCC1[N:7]1[C:15]2[C:10](=[CH:11][C:12]([C:16]([NH2:18])=[O:17])=[CH:13][CH:14]=2)[C:9]([C:19]2[CH:24]=[CH:23][CH:22]=[C:21]([NH:25][C:26](=[O:35])[CH2:27][CH2:28][CH:29]3[CH2:34][CH2:33][CH2:32][NH:31][CH2:30]3)[CH:20]=2)=[N:8]1>C1(C)C=CC=CC=1>[NH:31]1[CH2:32][CH2:33][CH2:34][CH:29]([CH2:28][CH2:27][C:26]([NH:25][C:21]2[CH:20]=[C:19]([C:9]3[C:10]4[C:15](=[CH:14][CH:13]=[C:12]([C:16]([NH2:18])=[O:17])[CH:11]=4)[NH:7][N:8]=3)[CH:24]=[CH:23][CH:22]=2)=[O:35])[CH2:30]1

Participants

3

Procedure

1-Perhydro-2H-pyran-2-yl-3-[3-(3-piperidylpropanoylamino)phenyl]-1H-indazole-5-carboxamide was suspended in 20 mL of toluene and HCl gas was bubbled through for 15 min. The reaction mixture became gummy and was stirred at room temperature overnight. The supernatant solution was decanted and the residue was purified by preparatory HPLC. (0.017 g, 7% yield over 2 steps): 1H NMR (DMSO d6) δ 13.48 (s, 1H), 10.38 (s, 1H), 8.62 (s, 1H), 8.1 (s, 1H), 7.94 (dd, 1H), 7.94 (dd, 1H), 7.73 (d, 1H), 7.62 (d, 1H), 7.48 (t, 1H), 7.36 (br s, 1H), 2.65 (m, 2H), 2.5 (m, 2H), 2.4 (br s, 4H), 1.52 (m, 4H), 1.40 (m, 2H); ES-MS (m/z) 392 [M+H]+.

Workup

  1. customHCl gas was bubbled through for 15 min
  2. customThe supernatant solution was decanted
  3. customthe residue was purified by preparatory HPLC

Sources & evidence

ORD record
ord-dbc61127542a4b4b8b45ef45b7fb3c16
Source dataset
uspto-grants-2007_05
Patent number
US07211594B2

Reaction notes

Loading…